| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Hyep Ivan serves as a Chief Financial Officer at BCAX. Across recent SEC filings that breaks down to 0 buys and 17 sells. Those positions are worth an estimated $492K at current prices.
Historically, Hyep Ivan's trades have earned a middling insider score of 62/100 across 7 rated trades. On a 3-month view, 85.7% of the rated trades came out ahead, averaging +9.3% over three months.
The biggest single holding is BCAX (~$492K) as Chief Financial Officer. The recent filings there lean toward selling, a net 150,900 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 30,385 | $18.21 | $553,198.15 | -17.3% | -10.1% | -4.1% |